Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Detection of Cerebrospinal Fluid Neurofilament Light Chain as a Marker for Alpha-Synucleinopathies.
Front Aging Neurosci. 2021 Sep 22;13:717930. doi: 10.3389/fnagi.2021.717930. eCollection 2021.
Front Aging Neurosci. 2021.
PMID: 34630068
Free PMC article.
Validation of Plasma Neurofilament Light Chain as a Marker for α-Synucleinopathies.
Schmitz M, Canaslan S, Villar-Piqué A, Gmitterová K, Varges D, Lingor P, Llorens F, Hermann P, Maass F, Zerr I.
Schmitz M, et al. Among authors: canaslan s.
Mov Disord. 2021 Nov;36(11):2701-2703. doi: 10.1002/mds.28724. Epub 2021 Aug 11.
Mov Disord. 2021.
PMID: 34379333
No abstract available.
Item in Clipboard
Plasma neurofilament light chain as a biomarker for fatal familial insomnia.
Hermann P, Canaslan S, Villar-Piqué A, Bunck T, Goebel S, Llorens F, Schmitz M, Zerr I.
Hermann P, et al. Among authors: canaslan s.
Eur J Neurol. 2022 Jun;29(6):1841-1846. doi: 10.1111/ene.15302. Epub 2022 Mar 7.
Eur J Neurol. 2022.
PMID: 35212083
Item in Clipboard
Validation of Plasma and CSF Neurofilament Light Chain as an Early Marker for Sporadic Creutzfeldt-Jakob Disease.
Schmitz M, Canaslan S, Espinosa JC, Fernández-Borges N, Villar-Piqué A, Llorens F, Varges D, Maass F, Torres JM, Hermann P, Zerr I.
Schmitz M, et al. Among authors: canaslan s.
Mol Neurobiol. 2022 Sep;59(9):1-9. doi: 10.1007/s12035-022-02891-7. Epub 2022 Jun 18.
Mol Neurobiol. 2022.
PMID: 35716271
Item in Clipboard
Cerebrospinal Fluid Iron-Ferritin Ratio as a Potential Progression Marker for Parkinson's Disease.
Maass F, Michalke B, Willkommen D, Canaslan S, Schmitz M, Bähr M, Zerr I, Lingor P.
Maass F, et al. Among authors: canaslan s.
Mov Disord. 2021 Dec;36(12):2967-2969. doi: 10.1002/mds.28790. Epub 2021 Sep 23.
Mov Disord. 2021.
PMID: 34553776
Item in Clipboard
Correction: Comparative evaluation of clinical and cerebrospinal fluid biomarker characteristics in rapidly and non‑rapidly progressive Alzheimer's disease.
Herden JM, Hermann P, Schmidt I, Dittmar K, Canaslan S, Weglage L, Nuhn S, Volpers C, Schlung A, Goebel S, Kück F, Villar-Piqué A, Schmidt C, Wedekind D, Zerr I.
Herden JM, et al. Among authors: canaslan s.
Alzheimers Res Ther. 2023 Jun 22;15(1):116. doi: 10.1186/s13195-023-01263-0.
Alzheimers Res Ther. 2023.
PMID: 37349779
Free PMC article.
No abstract available.
Item in Clipboard
Comparative evaluation of clinical and cerebrospinal fluid biomarker characteristics in rapidly and non-rapidly progressive Alzheimer's disease.
Herden JM, Hermann P, Schmidt I, Dittmar K, Canaslan S, Weglage L, Nuhn S, Volpers C, Schlung A, Goebel S, Kück F, Villar-Piqué A, Schmidt C, Wedekind D, Zerr I.
Herden JM, et al. Among authors: canaslan s.
Alzheimers Res Ther. 2023 Jun 8;15(1):106. doi: 10.1186/s13195-023-01249-y.
Alzheimers Res Ther. 2023.
PMID: 37291640
Free PMC article.
Item in Clipboard
α-Synuclein conformers reveal link to clinical heterogeneity of α-synucleinopathies.
Schmitz M, Candelise N, Canaslan S, Altmeppen HC, Matschke J, Glatzel M, Younas N, Zafar S, Hermann P, Zerr I.
Schmitz M, et al. Among authors: canaslan s.
Transl Neurodegener. 2023 Mar 14;12(1):12. doi: 10.1186/s40035-023-00342-4.
Transl Neurodegener. 2023.
PMID: 36915212
Free PMC article.
Review.
Item in Clipboard
Cite
Cite